1. Home
  2. MASS vs NSPR Comparison

MASS vs NSPR Comparison

Compare MASS & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 908 Devices Inc.

MASS

908 Devices Inc.

HOLD

Current Price

$5.96

Market Cap

324.4M

Sector

Health Care

ML Signal

HOLD

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.93

Market Cap

81.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MASS
NSPR
Founded
2012
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
324.4M
81.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
MASS
NSPR
Price
$5.96
$1.93
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$9.00
$4.50
AVG Volume (30 Days)
361.8K
101.4K
Earning Date
11-10-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$65,045,000.00
$7,779,000.00
Revenue This Year
N/A
$22.76
Revenue Next Year
$19.55
$75.45
P/E Ratio
N/A
N/A
Revenue Growth
36.21
14.04
52 Week Low
$1.81
$1.59
52 Week High
$9.34
$3.80

Technical Indicators

Market Signals
Indicator
MASS
NSPR
Relative Strength Index (RSI) 39.13 48.80
Support Level $6.26 $1.74
Resistance Level $6.83 $2.00
Average True Range (ATR) 0.39 0.12
MACD 0.07 0.01
Stochastic Oscillator 7.94 53.85

Price Performance

Historical Comparison
MASS
NSPR

About MASS 908 Devices Inc.

908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: